Skip to main content
SpringerLink
Log in
Book cover

Klinische Kardiologie pp 335–355Cite as

Kardiomyopathien

  • Chapter

  • 12k Accesses

Zusammenfassung

Nach der WHO-Einteilung (Richardson et al. 1996) werden Kardiomyopathien als Erkrankungen des Myokards, die mit einer kardialen Dysfunktion einhergehen, definiert. In den letzten Jahren wurde zunehmend deutlich, dass die Ursachen von Kardiomyopathien sehr vielfältig sein können. Es hat sich dabei insbesondere eine erhebliche Bedeutung genetischer Störungen gezeigt. Dementsprechend wurde kürzlich eine neue Definition und Einteilung der Kardiomyopathien von der American Heart Association empfohlen (Maron et al. 2006). Hier werden Kardiomyopathien als eine heterogene Gruppe von Erkrankungen des Myokards definiert, die mit einer mechanischen und/oder elektrischen Dysfunktion assoziiert sind, häufig eine genetische Ursache haben und mit einer Hypertrophie oder Dilatation des Herzens einhergehen können.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   139.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Abelmann WH, Lorell BH (1989) The challenge of cardiomyopathy. J Am Coll Cardiol 13: 1219–1239

    Article  PubMed  CAS  Google Scholar 

  • Akasaka T, Yoshikawa J, Yoshida K (1994) Phasic coronary flow characteristics in patients with hypertrophic cardiomyopathy: a study by coronary doppler catheter. J Am Soc Echocardiogr 7: 9–19

    PubMed  CAS  Google Scholar 

  • Anan R, Greve G, Thierfelder L et al. (1994) Prognostic implications of novel β-myosin heavy chain gene mutations that cause familial hypertrophic cardiomyopathy. J Clin Invest 93: 280–285

    Article  PubMed  CAS  Google Scholar 

  • Baumhäkel M, Kindermann I, Kindermann M et al. (2003) Isolated noncompaction of ventricular myocardium syndrome – a rare structural heart disease. Dtsch Med Wochenschr 128(11): 562–567

    Article  PubMed  Google Scholar 

  • Baig MK, Goldman JH, Caforio AL et al. (1998) Familial dilated cardiomyopathy: cardiac abnormalities are common in asymptomatic relatives and may represent early disease. J Am Coll Cardiol 31: 195–201

    Article  PubMed  CAS  Google Scholar 

  • Berger PB, Duffy J, Reeder GS et al. (1994) Restrictive cardiomyopathy associated with the eosinophilia-myalgia syndrome. Mayo Clin Proc 69: 162–165

    PubMed  CAS  Google Scholar 

  • Bowles NE, Ni J, Marcus F, Towbin JA (2002) The detection of cardiotropic viruses in the myocardium of patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. J Am Coll Cardiol 39: 892– 895

    Article  PubMed  Google Scholar 

  • Brouwer CA, Gietema JA, Berg MP van den et al. (2006) Long-term cardiac follow-up in survivors of a malignant bone tumour. Ann Oncol 17(10): 1586–1591

    Article  PubMed  CAS  Google Scholar 

  • Cannan CR, Reeder GS, Bailey KR (1995) Natural history of hypertrophic cardiomyopathy: a population based study, 1976 through 1990. Circulation 92: 2488–2495

    PubMed  CAS  Google Scholar 

  • Cardinale D, Sandri MT, Colombo A et al. (2004) Prognostic value of troponin I in cardiac risk stratification of cancer patients undergoing highdose chemotherapy. Circulation 109(22): 2749–2754

    Article  PubMed  CAS  Google Scholar 

  • Cecchetti G, Binda A, Piperno A et al. (1991) Cardiac alterations in 36 consecutive patients with idiopathic hemochromatosis: polygraphic and echocardiographic evaluation. Eur Heart J 12: 224–230

    PubMed  CAS  Google Scholar 

  • Cerqueira MD, Harp GD, Ritchie JL (1991) Rarity of preclinical alcoholic cardiomyopathy in chronic alcoholics <40 years of age. Am J Cardiol 67: 183–187

    Article  PubMed  CAS  Google Scholar 

  • Cheng TO (1997) Another cause for deep T-wave inversion. ACC Curr J Rev 6: 116

    Article  Google Scholar 

  • Child JS, Perloff JK (1988) The restrictive cardiomyopathies. Cardiol Clin 6: 289–316

    PubMed  CAS  Google Scholar 

  • Codd MB, Sugrue DD, Gersh BJ, Melton LJ (1989) Epidemiology of idiopathic dilated and hypertrophic cardiomyopathy: a population based study in Olmsted County, Minnesota. Circulation 80: 564–572

    PubMed  CAS  Google Scholar 

  • Cooper LT, Baughman KL, Feldman AM et al. (2007) The role of endomyocardial biopsy in the management of cardiovascular disease: A scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Circulation 116: 2216–2233

    Article  PubMed  Google Scholar 

  • Dabrowska B, Dabrowski A, Pruszczy KP (1995) Heart rate variability in pheochromocytoma. Am J Cardiol 76: 1202–1204

    Article  PubMed  CAS  Google Scholar 

  • Dansky HM, Buttrick PM (1994) Unravelling the genetic basis of dilated cardiomyopathy. Heart Fail 10: 5–10

    Google Scholar 

  • Davies MJ, McKenna WJ (1995) Hypertrophic cardiomyopathy: pathology and pathogenesis. Histopathology 26: 493–500

    Article  PubMed  CAS  Google Scholar 

  • Factor SM, Butany J, Sole MJ (1991) Pathological fibrosis and matric connective tissue in the subaortic myocardium of patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 17: 1343–1351

    Article  PubMed  CAS  Google Scholar 

  • Fagius J, Westermark K, Karlsson A (1990) Baroreflex-governed sympathetic outflow to muscle vasculature is increased in hypothyroidism. Clin Endocrinol 33: 177–185

    Article  CAS  Google Scholar 

  • Fananapazir L, Epstein ND, Curiel RV (1994) Long-term results of dual chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy: evidence for progressive symptomatic and hemodynamic improvement and reduction of left ventricular hypertrophy. Circulation 90: 2731–2742

    PubMed  CAS  Google Scholar 

  • Felice PV, Sawicki J, Anto J (1993) Endomyocardial disease and eosinophilia. Angiology 44: 869–874

    Article  PubMed  CAS  Google Scholar 

  • Fitzpatrick AP, Shapiro LM, Richards AF, Poole-Wilson PA (1990) Familial restrictive cardiomyopathy with atrioventricular block and skeletal myopathy. Br Heart J 63: 114–118

    Article  PubMed  CAS  Google Scholar 

  • Fontaine G, Fontaliran F, Lascault G et al. (1994) Arrhythmogenic right ventricular dysplasia. In: Zipes DP, Jalife J (eds) Cardiac electrophysiology: from cell to bedside. Saunders, Philadelphia, p 754

    Google Scholar 

  • Force T, Krause DS, Etten RA van (2007) Molecular mechanisms of cardiotoxicity of tyrosine kinase inhibition. Nat Rev Cancer 7(5): 332–344

    Article  PubMed  CAS  Google Scholar 

  • Gerlis LM, Schmit-Ott SC, Ho SY, Anderson RH (1993) Dysplastic conditions of the right ventricular myocardium: Uhls anomaly vs. arrhythmogenic right ventricular dysplasia. Br Heart J 69: 142–150

    Article  PubMed  CAS  Google Scholar 

  • Gertz MA, Kyle RA (1991) Secondary systemic amyloidosis: response and survival in 64 patients. Medicine 70: 246–252

    Article  PubMed  CAS  Google Scholar 

  • Gleichmann U, Seggewiss H, Faber L (1996) Catheter treatment of hypertrophic cardiomyopathy. Dtsch Med Wochenschr 121: 679–685

    Article  PubMed  CAS  Google Scholar 

  • Hamid MS, Norman M, Quraishi A et al. (2002) Prospective evaluation of relatives for familial arrhythmogen right ventricular cardiomyopathy/ dysplasia reveals a need to broaden diagnostic criteria. J Am Coll Cardiol 40: 1445–1450

    Article  PubMed  Google Scholar 

  • Hausdorf G, Rieger U, Koepp P (1988) Cardiomyopathy in childhood diabetes mellitus: incidence, time of onset, and relation to metabolic control. Int J Cardiol 19: 225–333

    Article  PubMed  CAS  Google Scholar 

  • James TN (1994) Normal and abnormal consequences of apoptosis as a possible cause of gradual development of complete heart block and fatal arrhythmias associated with absence of the AV mode, the sinus node and the internodal pathways. Circulation 90: 556–573

    PubMed  CAS  Google Scholar 

  • Jonkman FAM, Jong G de, Fioretti PM (1997) Growth hormone in the treatment of heart failure: a new tool for the future? Eur Heart J 18: 181– 184

    PubMed  CAS  Google Scholar 

  • Kahaly G, Stover C, Beyer J, Mohr-Kahaly S (1992) Relation of endocrine and cardiac findings in acromegalics. J Endocrinol Invest 15: 13–18

    PubMed  CAS  Google Scholar 

  • Katritsis D, Wilmshurst PT, Wendon JA et al. (1991) Primary restrictive cardiomyopathy: clinical and pathologic characteristics. J Am Coll Cardiol 18: 1230–1235

    Article  PubMed  CAS  Google Scholar 

  • Kelly DP, Strauss AW (1994) Inherited cardiomyopathies. N Engl J Med 330: 930–932

    Article  Google Scholar 

  • Keren A, Popp RL (1992) Assignment of patients into the classification of cardiomyopathies. Circulation 86: 1622–1633

    PubMed  CAS  Google Scholar 

  • Klein AL, Hatle LK, Taliercio CP et al. (1991) Prognostic significance of doppler measures of diastolic function in cardiac amyloidosis. A doppler echocardiography study. Circulation 83: 808–816

    PubMed  CAS  Google Scholar 

  • Koskinen P, Kupari M (1992) Alcohol and cardiac arrhythmicas. BMJ 304: 1394–1395

    Article  PubMed  CAS  Google Scholar 

  • Kramer K, Kuller L, Fisker R (1968) The increasing mortality attributed to cirrhosis and fatty liver, in Baltimore (1957–1966). Ann Int Med 69: 273–282

    PubMed  CAS  Google Scholar 

  • Kupari M, Koskinen P, Suokas A, Ventila M (1990) Left ventricular filling impairment in asymptomatic chronic alcoholics. Am J Cardiol 66: 1473–1477

    Article  PubMed  CAS  Google Scholar 

  • Kushawa SS, Fallon JT, Fuster V (1997) Restrictive cardiomyopathy. N Engl J Med 336: 267–276

    Article  Google Scholar 

  • Kyle RA, Gertz MA, Greipp PR et al. (1993) Phase II trial of recombinant interferon alfa-2 in the treatment of primary systemic amyloidosis. Am J Hematol 44: 125–128

    Article  PubMed  Google Scholar 

  • Kyle RA, Gertz MA, Greipp PR et al. (1997) A trial of three regimens for primary amyloidosis: colchicine alone, melphalan and prednisone, and melphalan, prednisone and colchicine. N Engl J Med 336: 1202–1207

    Article  PubMed  CAS  Google Scholar 

  • Lever HM, Karam RF, Currie PJ, Healy BP (1989) Hypertrophic cardiomyopathy in the elderly. Distinctions from the young based on cardiac shape. Circulation 79: 580–588

    PubMed  CAS  Google Scholar 

  • Lewis JF, Maron BJ (1989) Elderly patients with hypertrophic cardiomyopathy: a subset with distinctive left ventricular morphology and progressive clinical course late in life. J Am Coll Cardiol 13: 36–42

    Article  PubMed  CAS  Google Scholar 

  • Lombes M, Alfaidy N, Eugene E (1995) Prerequisite for cardiac aldosterone action. Mineralocorticoid receptor and 11 beta-hydroxysteroid dehydrogenase in the human heart. Circulation 92: 175–182

    PubMed  CAS  Google Scholar 

  • Manolio TA, Levy D, Garrison RJ (1991) Relation of alcohol intake to left ventricular mass: the Framingham study. J Am Coll Cardiol 17: 717–721

    Article  PubMed  CAS  Google Scholar 

  • Marcus FI (1997) Is arrhythmogenic right ventricular dysplasia, Uhls anomaly, and right ventricular outflow tract tachycardia a spectrum of the same disease? Cardiol Rev 5: 25–29

    Article  Google Scholar 

  • Marcus FI, Fontaine GH, Guiraudon G (1982) Right ventricular dysplasia: a report of 24 adult cases. Circulation 65: 384–398

    PubMed  CAS  Google Scholar 

  • Maron BJ (1997) Hypertrophic cardiomyopathy. Lancet 350: 127–133

    Article  PubMed  CAS  Google Scholar 

  • Maron BJ, Roberts WC (1979) Quantitative analysis of cardiac muscle cell disorganisation in the ventricular septum of patients with hypertrophic cardiomyopathy. Circulation 59: 689–706

    PubMed  CAS  Google Scholar 

  • Maron BJ, Savage DD, Wolfson JK, Epstein SE (1981) Prognosis significance of 24 hour ambulatory electrocardiographic monitoring in patients with hypertrophic cardiomyopathy: a prospective study. Am J Cardiol 48: 252–257

    Article  PubMed  CAS  Google Scholar 

  • Maron BJ, Wolfson JK, Epstein SE, Roberts WC (1986) Intramural (»small vessel«) coronary artery disease in hypertrophic cardiomyopathy. J Am Coll Cardiol 8: 545

    Article  PubMed  CAS  Google Scholar 

  • Maron BJ, Peterson EE, Maron MS, Peterson JE (1994) Prevalence of hypertrophic cardiomyopathy in an outpatient referred for echocardiographic study. Am J Cardiol 73: 577–580

    Article  PubMed  CAS  Google Scholar 

  • Maron BJ, Nishimura RA, McKenna WJ et al. (1999) Assessment of permanent dual-chamber pacing as a treatment for drug-refractory symptomatic patients with obstructive hypertrophic cardiomyopathy. Circulation 99: 2927–2933

    PubMed  CAS  Google Scholar 

  • Maron BJ, Towbin JA, Thiene G et al. (2006) Contemporary definitions and classification of the cardiomyopathies. Circulation 113: 1807–1816

    Article  PubMed  Google Scholar 

  • Maugans TA, Coates ML (1995) Diagnosis and treatment of acromegaly. Am Fam Physician 52: 207–214

    PubMed  CAS  Google Scholar 

  • McManus BM, Bren GB, Robertson EA (1981) Hemodynamic cardiac constriction without anatomic myocardial restriction or pericardial constriction. Am Heart J 102: 134–136

    Article  PubMed  CAS  Google Scholar 

  • McKenna WJ, Behr ER (2002) Hypertrophic cardiomyopathy: management, risk stratification and prevention of sudden death. Heart 87: 169–176

    Article  PubMed  Google Scholar 

  • McKenna WJ, Deanfield J, Faruqui A (1981) Prognosis in hypertrophic cardiomyopathy: role of age and clinical, electrocardiographic and haemodynamic features. Am J Cardiol 47: 532–538

    Article  PubMed  CAS  Google Scholar 

  • McKenna WJ, Thiene G, Nava A et al. (1994) Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Br Heart J 71: 215–218

    Article  PubMed  CAS  Google Scholar 

  • McManus BM, Fleury TA, Roberts WC (1981) Fatal catecholamine crisis in pheochromocytoma. Am Heart J 102: 930

    Article  PubMed  CAS  Google Scholar 

  • Mestroni L, Maisch B, McKenna WJ et al. on behalf of the Collaborative Research Group of the European Human and Capital Mobility Project on Familial Dilated Cardiomyopathy (1999a) Guidelines for the study of familial dilated cardiomyopathies. Eur Heart J 20: 93–102

    Google Scholar 

  • Mestroni L, Rocco C, Gregori D et al. (1999b) Familial dilated cardiomyopathy: evidence for genetic and phenotypic heterogeneity. J Am Coll Cardiol 34: 181–190

    Article  CAS  Google Scholar 

  • Nef HM, Möllmann H, Elsässer A (2007) Tako-tsubo cardiomyopathy (apical ballooning). Heart 93: 1309–1315

    Article  PubMed  Google Scholar 

  • Niimura H, Bachinski LL, Sangwatanaroj S et al. (1998) Mutations in the gene for cardiac myosin-bindin protein C and late-onset familial hypertrophic cardiomyopathy. N Engl J Med 338: 1248–1257

    Article  PubMed  CAS  Google Scholar 

  • Perrot A, Osterziel KJ, Beck M et al. (2002) Fabry disease: focus on cardiac manifestations and molecular mechanisms. Herz 27(7): 699–702

    Article  PubMed  Google Scholar 

  • Polikar R, Burger AG, Scherrer U, Nicod P (1993) The thyroid and the heart. Circulation 87: 1435–1441

    PubMed  CAS  Google Scholar 

  • Regan TJ (1990) Alcohol and the cardiovascular system. JAMA 264: 377– 381

    Article  PubMed  CAS  Google Scholar 

  • Richardson P, McKenna W, Bristow W et al. (1996) Report of the 1995 World Health Organization/International Society and Feration of Cardiology Task Force on the Definition and Classification of Cardiomyopathies. Circulation 93: 841–842

    PubMed  CAS  Google Scholar 

  • Robinson K, Frenneaux MP, Stockins B (1990) Atrial fibrillation in hypertrophic cardiomyopathy: a longitudinal study. J Am Coll Cardiol 15: 1279–1285

    Article  PubMed  CAS  Google Scholar 

  • Rossi GP, Sacchetto A, Pavan E (1997) Remodeling of the left ventricle in primary aldosteronism due to Conns adenoma. Circulation 95: 1471– 1478

    PubMed  CAS  Google Scholar 

  • Ruder MA, Winston SA, Davis JC et al. (1985) Arrhythmogenic right ventricular dysplasia in a family. Am J Cardiol 59: 799–803

    Article  Google Scholar 

  • Ruvers H, Garrahy P, Robinson W, Murphy A (1987) Reversible cardiac dysfunction in hemochromatosis. Am Heart J 113: 216–217

    Article  Google Scholar 

  • Scheidt W von, Eng CM, Fitzmaurice TF et al. (1991) An atypical variant of Fabrys disease with manifestation confined to the myocardium. N Engl J Med 324: 395–399

    Article  Google Scholar 

  • Schulman LN, Braunwald E (1997) Hematological-oncological disorders and heart disease. In: Braunwald E (ed) Heart disease. A textbook of cardiovascular medicine. Saunders, Philadelphia, pp 1786–1808

    Google Scholar 

  • Scott I, Parkes R, Cameron DP (1988) Pheochromocytoma and cardiomyopathy. Med J Aust 148: 94–99

    PubMed  CAS  Google Scholar 

  • Shabetai R (1992) Controversial issues in restrictive cardiomyopathy. Postgrad Med J 68: 47–51

    Article  Google Scholar 

  • Shamim W, Yousufuddin M, Wang D et al. (2002) Nonsurgical reduction of the interventricular septum in patients with hypertrophic cardiomypathy. N Engl J Med 347: 1326–1333

    Article  PubMed  Google Scholar 

  • Sharma OP (1994) Myocardial sarcoidosis. A wolf in sheeps clothing. Chest 106: 988–990

    Article  PubMed  CAS  Google Scholar 

  • Sigwart U (1995) Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy. Lancet 346: 211–214

    Article  PubMed  CAS  Google Scholar 

  • Skinner M, Anderson JJ, Simms R et al. (1996) Treatment of 100 patients with primary amyloidisis; a randomized trial of melphalan, prednisone, and colchicine vs. colchicine alone. Am J Med 100: 290–298

    Article  PubMed  CAS  Google Scholar 

  • Spirito P, Maron BJ (1984) Patterns of systolic anterior motion of the mitral valve in hypertrophic cardiomyopathy: assessment by two-dimensional echocardiography. Am J Cardiol 54: 1039–1046

    Article  PubMed  CAS  Google Scholar 

  • Spirito P, Chiarella F, Carratino L (1989) Clinical course and prognosis of hypertrophic cardiomyopathy in an outpatients population. N Engl J Med 320: 749–755

    Article  PubMed  CAS  Google Scholar 

  • Spirito P, Seidman CE, McKenna WJ, Maron BJ (1997) The management of hypertrophic cardiomyopathy. N Engl J Med 336(11): 775–785

    Article  PubMed  CAS  Google Scholar 

  • Stafford WJ, Trohman RG, Bilsker M (1986) Cardiac arrest in an adolescent with atrial fibrillation and hypertrophic cardiomyopathy. J Am Coll Cardiol 7: 701–704

    Article  PubMed  CAS  Google Scholar 

  • Thiene G, Nava AM, Abgekubu A et al. (1990) Anatomoclinical aspects of arrhythmogenic right ventricular cardiomyopathy. In: Baroldi G, Camerini F, Goodwin FJ (eds) Advances in cardiomyopathies. Springer, Berlin Heidelberg New York Tokio, pp 397–408

    Google Scholar 

  • Thierfelder L (1998) Genetics of dilated cardiomyopathy. Med Klin 93: 210–214

    Article  CAS  Google Scholar 

  • Uhl HSM (1972) A previously undescribed congenital malformation of the heart: almost total absence of the myocardium of the right ventricle. Bull Johns Hopkins Hos 91: 197–209

    Google Scholar 

  • Urbano-Marquez A, Estruch R, Fernandez Sola J (1995) The greater risk of alcoholic cardiomyopathy and myopathy in women compared to men. J Am Coll Cardiol 274: 149–154

    CAS  Google Scholar 

  • Weller PF, Bubley GJ (1994) The idiopathic hypereosinophilic syndrome. Blood 83: 2759–2779

    PubMed  CAS  Google Scholar 

  • Werbel SS, Ober KP (1995) Pheochromocytoma: update on diagnosis, localization, and management. Med Clin North Am 79: 131–153

    PubMed  CAS  Google Scholar 

  • White PC (1994) Disorders of aldosterone biosynthesis and action. N Engl J Med 331: 250–258

    Article  PubMed  CAS  Google Scholar 

  • Wittstein IS, Thiemann DR, Lima JA, et al. (2005) Neurohumoral features of myocardial stunning due to sudden emotional stress. N Engl J Med 352: 539–548

    Article  PubMed  CAS  Google Scholar 

  • Yamabe H, Okumura K, Tsuchiya T (1994) Demonstration of entrainment and presence of slow conduction during ventricular tachycardia in arrhythmogenic right ventricular dysplasia. Pacing Clin Electrophysiol 17: 172–178

    Article  PubMed  CAS  Google Scholar 

  • Yamaguchi H, Ishimura T, Nishiyam S (1979) Hypertrophic nonobstructive cardiomyopathy with giant negative T-waves (apical hypertrophy): ventriculographic and echocardiographic features in 30 patients. Am J Cardiol 44: 401–423

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik für Innere Medizin III, Universitätsklinikum des Saarlandes, Homburg/Saar, Kirrberger Straße, 66421, Germany

    Dr. med. H. Kilter

  2. Klinik und Poliklinik für Innere Medizin III, Universitätsklinikum des Saarlandes, Homburg/Saar, Kirrberger Straße, 66421, Germany

    Prof. Dr. med. M. Böhm

Authors
  1. Dr. med. H. Kilter
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Prof. Dr. med. M. Böhm
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Klinik für Kardiologie, Angiologie, Pneumologie und Internistische Intensivmedizin, Herzzentrum der Universität zu Köln, Kerpener Straße 62, 50937, Köln

    Erland Erdmann

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Medizin Verlag Heidelberg

About this chapter

Cite this chapter

Kilter, H., Böhm, M. (2011). Kardiomyopathien. In: Erdmann, E. (eds) Klinische Kardiologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-16481-1_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-16481-1_12

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-16480-4

  • Online ISBN: 978-3-642-16481-1

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation